Based on the preliminary experimental results that TTC17 had a more obvious and stable effect on the malignant phenotype of breast cancer than other candidate molecules and our literature review assessing the current status of few studies on TTC17, we finally chose TTC17 for further study. This evidence concerns the gene TTC17 and breast carcinoma.